STELLANTIS NV (STLAP.PA) Fundamental Analysis & Valuation

EPA:STLAP • NL00150001Q9

6.172 EUR
-0.12 (-1.83%)
Last: Mar 6, 2026, 07:00 PM

This STLAP.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

STLAP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 31 industry peers in the Automobiles industry. STLAP has a bad profitability rating. Also its financial health evaluation is rather negative. STLAP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. STLAP.PA Profitability Analysis

1.1 Basic Checks

  • STLAP had negative earnings in the past year.
  • In the past year STLAP has reported a negative cash flow from operations.
  • In the past 5 years STLAP has always been profitable.
  • In the past 5 years STLAP always reported a positive cash flow from operatings.
STLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFSTLAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

1.2 Ratios

  • STLAP has a worse Return On Assets (-1.19%) than 61.29% of its industry peers.
  • STLAP's Return On Equity of -3.27% is in line compared to the rest of the industry. STLAP outperforms 41.94% of its industry peers.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
STLAP.PA Yearly ROA, ROE, ROICSTLAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • In the last couple of years the Profit Margin of STLAP has declined.
  • In the last couple of years the Operating Margin of STLAP has declined.
  • STLAP's Gross Margin of 7.74% is on the low side compared to the rest of the industry. STLAP is outperformed by 70.97% of its industry peers.
  • STLAP's Gross Margin has been stable in the last couple of years.
  • STLAP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
STLAP.PA Yearly Profit, Operating, Gross MarginsSTLAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. STLAP.PA Health Analysis

2.1 Basic Checks

  • STLAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for STLAP has been reduced compared to 1 year ago.
  • The number of shares outstanding for STLAP has been increased compared to 5 years ago.
  • STLAP has a worse debt/assets ratio than last year.
STLAP.PA Yearly Shares OutstandingSTLAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
STLAP.PA Yearly Total Debt VS Total AssetsSTLAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • Based on the Altman-Z score of 1.31, we must say that STLAP is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.31, STLAP is in line with its industry, outperforming 58.06% of the companies in the same industry.
  • A Debt/Equity ratio of 0.38 indicates that STLAP is not too dependend on debt financing.
  • The Debt to Equity ratio of STLAP (0.38) is better than 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACCN/A
WACC6.74%
STLAP.PA Yearly LT Debt VS Equity VS FCFSTLAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B

2.3 Liquidity

  • STLAP has a Current Ratio of 1.06. This is a normal value and indicates that STLAP is financially healthy and should not expect problems in meeting its short term obligations.
  • STLAP has a Current ratio of 1.06. This is in the lower half of the industry: STLAP underperforms 67.74% of its industry peers.
  • STLAP has a Quick Ratio of 1.06. This is a bad value and indicates that STLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • STLAP has a Quick ratio of 0.77. This is in the lower half of the industry: STLAP underperforms 70.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
STLAP.PA Yearly Current Assets VS Current LiabilitesSTLAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. STLAP.PA Growth Analysis

3.1 Past

  • STLAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.87%.
  • The earnings per share for STLAP have been decreasing by -15.26% on average. This is quite bad
  • The Revenue for STLAP has decreased by -17.07% in the past year. This is quite bad
  • STLAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.72% yearly.
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%

3.2 Future

  • Based on estimates for the next years, STLAP will show a small growth in Earnings Per Share. The EPS will grow by 5.95% on average per year.
  • Based on estimates for the next years, STLAP will show a small growth in Revenue. The Revenue will grow by 3.12% on average per year.
EPS Next Y-95.93%
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%
EPS Next 5Y5.95%
Revenue Next Year-2.19%
Revenue Next 2Y1.33%
Revenue Next 3Y2.16%
Revenue Next 5Y3.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
STLAP.PA Yearly Revenue VS EstimatesSTLAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B
STLAP.PA Yearly EPS VS EstimatesSTLAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

3

4. STLAP.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • STLAP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • STLAP is valuated cheaply with a Price/Forward Earnings ratio of 4.20.
  • Based on the Price/Forward Earnings ratio, STLAP is valued cheaply inside the industry as 83.87% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. STLAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.2
STLAP.PA Price Earnings VS Forward Price EarningsSTLAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • 70.97% of the companies in the same industry are more expensive than STLAP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.42
STLAP.PA Per share dataSTLAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%

0

5. STLAP.PA Dividend Analysis

5.1 Amount

  • STLAP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

STLAP.PA Fundamentals: All Metrics, Ratios and Statistics

STELLANTIS NV

EPA:STLAP (3/6/2026, 7:00:00 PM)

6.172

-0.12 (-1.83%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners45.78%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap17.92B
Revenue(TTM)146.12B
Net Income(TTM)-2.39B
Analysts71.11
Price Target8.45 (36.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.34
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.59%
PT rev (3m)-10.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-38.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.2
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.77
EV/EBITDA 5.42
EPS(TTM)-0.83
EYN/A
EPS(NY)1.47
Fwd EY23.82%
FCF(TTM)-4.67
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS50.32
BVpS25.18
TBVpS8.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)6.95%
ROA(5y)5.83%
ROE(3y)17.6%
ROE(5y)15.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)13.66%
ROCE(5y)12.71%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-28.95%
OM growth 5Y-7.06%
PM growth 3Y-28.4%
PM growth 5Y-10.63%
GM growth 3Y-13.66%
GM growth 5Y-1.49%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 6.13
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.31
F-Score1
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)140.23%
Cap/Depr(5y)152.03%
Cap/Sales(3y)5.82%
Cap/Sales(5y)6.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.87%
EPS 3Y-25.78%
EPS 5Y-15.26%
EPS Q2Q%-141.95%
EPS Next Y-95.93%
EPS Next 2Y-19.62%
EPS Next 3Y-1.29%
EPS Next 5Y5.95%
Revenue 1Y (TTM)-17.07%
Revenue growth 3Y1.64%
Revenue growth 5Y7.72%
Sales Q2Q%71.49%
Revenue Next Year-2.19%
Revenue Next 2Y1.33%
Revenue Next 3Y2.16%
Revenue Next 5Y3.12%
EBIT growth 1Y-115.72%
EBIT growth 3Y-27.78%
EBIT growth 5Y0.11%
EBIT Next Year-7.53%
EBIT Next 3Y23.04%
EBIT Next 5Y21.38%
FCF growth 1Y-193.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.94%
OCF growth 3Y-40.45%
OCF growth 5Y-18.8%

STELLANTIS NV / STLAP.PA FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to STLAP.PA.


What is the valuation status of STELLANTIS NV (STLAP.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to STELLANTIS NV (STLAP.PA). This can be considered as Overvalued.


What is the profitability of STLAP stock?

STELLANTIS NV (STLAP.PA) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for STLAP stock?

The Earnings per Share (EPS) of STELLANTIS NV (STLAP.PA) is expected to decline by -95.93% in the next year.


How sustainable is the dividend of STELLANTIS NV (STLAP.PA) stock?

The dividend rating of STELLANTIS NV (STLAP.PA) is 0 / 10 and the dividend payout ratio is -81.93%.